HRSA-23-127: A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2023.
Health Resources and Services Administration offered grants of up to $2.6 million to nonprofits, state and local governments and tribes. It expected to make one award worth $2.6 million in total. Applications closed on June 12, 2023.
From the official notice on Grants.gov, last changed June 6, 2023. Checked November 7, 2026.
- Award ceiling$2.6 million
- Total funding$2.6 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | April 12, 2023 |
|---|---|
| Deadline | June 12, 2023 |
Who can apply
This opportunity was open to nonprofits, state and local governments and tribes.
All 8 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible organizations include public and nonprofit private entities, including institutions of higher education and academic health science centers involved in addressing HIV related issues on a national scope. Faith-based and community-based organizations, Tribes, and tribal organizations also are eligible to apply. Applicants have the option to submit proposals with collaborating organizations if the partnership enhances the approach, capability and reach of the cooperative agreement.
Is this a realistic fit?
- Past Minority HIV/AIDS Fund (MHAF) awards averaged $1.2 million; this notice allows up to $2.6 million per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP). Funding will be provided to support a single organization to lead a multi-site evaluation and provide technical assistance (TA), including planning, coordination, mapping services, and infrastructure development/enhancement to a cohort of up to four implementation sites on the development of a status neutral framework, funded under a separate announcement number, HRSA-23-126: A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Implementation Sites. The ETAP will design an evaluation plan that will monitor the development, implementation, and outcomes of the four implementation sites’ status neutral activities to assess effectiveness and disseminate best practices and lessons learned for replication and expansion in other Ryan White HIV/AIDS Program (RWHAP) Part A programs, Center for Disease Control (CDC) directly-funded health departments and community-based organizations, as well as in the Bureau of Primary Health Care’s Primary Care HIV Prevention Program (PCHP). The CDC offers a self-paced, eLearning course on Status Neutral hosted on CDC TRAIN (https://www.train.org/cdctrain/welcome), which may be useful to the funding recipient. For more details, see Program Requirements and Expectations.
Who has won Minority HIV/AIDS Fund (MHAF) grants before
From fiscal 2021 to 2025, Minority HIV/AIDS Fund (MHAF) (93.899) awarded $26.9 million across 22 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Jsi Research & Training Institute Inc | Massachusetts | 2 | $8.4 million |
| The Trustees of Columbia University in the City of New York | New York | 1 | $3.5 million |
| African-American AIDS Policy and Training Institute | California | 1 | $1.9 million |
| Terros Inc | Arizona | 1 | $1.3 million |
| City of Vernon | California | 1 | $1.3 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-127 still open?
No. It closed on June 12, 2023.
Who can apply for A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP)?
Health Resources and Services Administration accepted applications from nonprofits, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP)?
Closed June 12, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $2.6 million each. About $2.6 million in total for one award.
Who has won Minority HIV/AIDS Fund (MHAF) grants before?
The largest recipients over five fiscal years were Jsi Research & Training Institute Inc, The Trustees of Columbia University in the City of New York, African-American AIDS Policy and Training Institute. The program made 22 awards worth $26.9 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)